ArticleStem cell reports2025
Human adrenocortical organoids for tissue regeneration and disease modeling.
Article in Stem cell reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Review
- Stem cell strategies for cell replacement therapy in endocrine diseases.Cell transplantationReview
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
13 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The adrenal glands are essential endocrine organs that secrete key hormones maintaining physiological homeostasis. Herein, we established expandable three-dimensional (3D) human adrenocortical organoid (ACO) cultures that preserved the characteristic of zona fasciculata cell lineages and retained their capacity to produce cortisol. The ACOs could secrete glucocorticoids in response to physiological stimuli and thus rescue adrenalectomized mice, indicating their potential for the treatment of primary adrenal insufficiency. Furthermore, by introducing a hotspot pathogenic variant (PRKACA L206R) identified in Cushing's syndrome, we achieved the organoid disease modeling of cortisol-producing adenomas. In summary, this study establishes a human organoid platform to explore homeostasis and dysfunction in adrenal glands, suggesting future applications in disease modeling and regenerative medicine.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.